Trump’s F.D.A. Pick Could Undo Decades of Drug Safeguards
Thursday, February 9, 2017 - 20:01
in Mathematics & Economics
A top candidate to head the agency, Jim O’Neill, advocates “progressive” approval, in which drugs proved safe could be sold to consumers even if not yet proved effective.